154 related articles for article (PubMed ID: 1649662)
21. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor localization in brain: relationship to motor and reward systems.
Herkenham M
Ann N Y Acad Sci; 1992 Jun; 654():19-32. PubMed ID: 1385932
[No Abstract] [Full Text] [Related]
23. Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.
Qureshi J; Saady M; Cardounel A; Kalimi M
Mol Cell Biochem; 1998 Apr; 181(1-2):21-7. PubMed ID: 9562238
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
[TBL] [Abstract][Full Text] [Related]
25. Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain.
Abood ME; Sauss C; Fan F; Tilton CL; Martin BR
Pharmacol Biochem Behav; 1993 Nov; 46(3):575-9. PubMed ID: 8278434
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.
García-Gil L; Romero J; Ramos JA; Fernández-Ruiz JJ
Drug Alcohol Depend; 1999 Jun; 55(1-2):127-36. PubMed ID: 10402157
[TBL] [Abstract][Full Text] [Related]
27. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain.
Bidaut-Russell M; Devane WA; Howlett AC
J Neurochem; 1990 Jul; 55(1):21-6. PubMed ID: 2162376
[TBL] [Abstract][Full Text] [Related]
29. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
32. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.
Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A
Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819
[TBL] [Abstract][Full Text] [Related]
33. Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.
Burston JJ; Wiley JL; Craig AA; Selley DE; Sim-Selley LJ
Br J Pharmacol; 2010 Sep; 161(1):103-12. PubMed ID: 20718743
[TBL] [Abstract][Full Text] [Related]
34. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
35. Large-scale analysis of gene expression changes during acute and chronic exposure to [Delta]9-THC in rats.
Kittler JT; Grigorenko EV; Clayton C; Zhuang SY; Bundey SC; Trower MM; Wallace D; Hampson R; Deadwyler S
Physiol Genomics; 2000 Sep; 3(3):175-85. PubMed ID: 11015613
[TBL] [Abstract][Full Text] [Related]
36. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
Anikwue R; Huffman JW; Martin ZL; Welch SP
J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
[TBL] [Abstract][Full Text] [Related]
37. The functional neuroanatomy of brain cannabinoid receptors.
Breivogel CS; Childers SR
Neurobiol Dis; 1998 Dec; 5(6 Pt B):417-31. PubMed ID: 9974175
[TBL] [Abstract][Full Text] [Related]
38. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
39. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
Yamamoto I; Kimura T; Kamei A; Yoshida H; Watanabe K; Ho IK; Yoshimura H
Biol Pharm Bull; 1998 Apr; 21(4):408-10. PubMed ID: 9586583
[TBL] [Abstract][Full Text] [Related]
40. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC.
Liddle J; Huffman JW; Wiley JL; Martin BR
Bioorg Med Chem Lett; 1998 Aug; 8(16):2223-6. PubMed ID: 9873517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
